Marijuana Industry By Application (Cancer, Arthritis, Alzheimer’s), By Product Type (Oils, Cream,Tinctures, Powder), and By Usage (Medical Use , Recreational Use)- Global Size Analysis and Market Forecast 2019-2025

ID: QBI-GRS-AR-134298 | Dec. 28, 2018 | Publisher : Global Reports Store | Number of Pages: 110

Global Marijuana Industry was valued at USD 17.2 Billion in the year 2017. Global Marijuana Industry is further estimated to grow at a CAGR of 22.9% from 2019 to reach USD 88.97 Billion by the year 2025. North America region holds the highest Industry share in 2017 and also considered as the fastest growing Industry in the forecasted period. At a country level, developed industries like the U.S., Canada holds a substantial Industry share in 2017 and it is projected to grow at a gradual pace in the coming years.

Major market players in Marijuana Industry are Canopy Growth Corp., GW Pharmaceuticals PLC, Medical Marijuana Inc., United Cannabis, Cannabis Sativa Inc., GreenGro Technologies, Aurora Cannabis, CannaGrow Holdings Inc., Cara Therapeutics., GBSciences Inc., Lexaria Bioscience Corp., Aphria and other brief information of 10 companies will be provided in the report. Rising research and development expenses to address the changing demand of end users. Similarly, growth strategies such as acquisition, merger, and expansion of the distribution network were few techniques adopted by most of the top players in the last 5 years.

SWOT Analysis of Marijuana Industry:
Strength:
Growing use of marijuana in the medical industry
Weakness:
The stigma of marijuana in society
Opportunities:
Increasing demand in healthcare and pharmaceutical industry
Threats:
Different government regulation in different countries

The Global Marijuana Industry is segmented on the basis of product types, application, usage, and region. By Application, pain management is expected to hold the highest Industry share during the forecast period. On the other hand, by usage, medical usage holds the highest Industry and also considered as fastest growing with highest CAGR during the year 2019-2025.

By Application
• Cancer
• Arthritis
• Alzheimer’s
• Pain Management
• Multiple Sclerosis
• Others

By Usage
• Medical Use
• Recreational Use

By Product Type
• Oils
• Cream
• Tinctures
• Powder
• Pills
• Others

By Region
North America
• USA
• Canada
Europe
• Germany
• U.K.
• France
• Italy
• Rest of Europe
APAC
• China
• India
• Japan
• Rest of Asia-Pacific
RoW
• Latin America
• Middle East & Africa
1. Introduction
1.1 Industry Vision
1.2 Limitations
1.3 Stakeholders
2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
2.1.1.1. Key Data from Secondary Research
2.1.2. Primary Research
2.1.2.1. Key Data from Primary Research
2.1.2.2. Breakdowns of Primary Interviews
2.2. Industry Size Estimation
2.2.1. Bottoms-Up Approach
2.2.2. Top-Down Approach
2.2.3. Annual Revenue Process
2.3. Data Triangulation
2.4. Research Assumptions
2.4.1. Assumption
3. Executive Summary
4. Industry Overview
4.1. Introduction
4.2. Strength
4.3. Weakness
4.4. Opportunities
4.5. Threats
4.6. Regulations
4.7. Supply Chain/Value Chain Analysis
4.8. Patent & Standards
5. Industry Trends
5.1. Introduction
5.2. Porter’s Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Buyers
5.2.4. Bargaining Power of Suppliers
5.2.5. Intensity of Competitive Rivalry
6. Marijuana Industry, By Product Type
6.1. Oils
6.2. Cream
6.3. Tinctures
6.4. Powder
6.5. Pills
6.6. Others
7. Marijuana Industry, By Application
7.1. Cancer
7.2. Arthritis
7.3. Alzheimer’s
7.4. Pain Management
7.5. Multiple Sclerosis
7.6. Others
8. Marijuana Industry, Usage
8.1. Medical Use
8.2. Recreational Use
9 Geographical Analysis
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. RoE
9.4. Asia Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. RoAPAC
9.5. RoW
9.5.1. Latin America
9.5.1.1. Brazil
9.5.1.2. Argentina
9.5.1.3. Rest of Latin America
9.5.2. Middle East and Africa
10. Company Profiles
10.1. Canopy Growth Corporation
10.1.1 Company Overview
10.1.2 Financial Overview
10.1.3 Product Overview
10.1.4 Current Development
10.2. GW Pharmaceuticals, PLC
10.3. Medical Marijuana, Inc.
10.4. United Cannabis
10.5. Cannabis Sativa, Inc.
10.6. GreenGro Technologies
10.7. Aurora Cannabis
10.8. CannaGrow Holdings, Inc.
10.9. Cara Therapeutics.
10.10. GBSciences, Inc.
10.11. Lexaria Bioscience Corp.
10.12. Aphria (Liberty Health Sciences)
11. Competitive Analysis
11.1. Introduction
11.2. Industry Positioning of Key Players
11.3 Competitive Strategies Adopted by Leading Players
11.3.1. Investments & Expansions
11.3.2. New Product Launches
11.3.3. Mergers & Acquisitions
11.3.4. Agreements, Joint Ventures, and Partnerships
12. Appendix
12.1. Questionnaire
12.2. Available Customizations
12.3. Upcoming Events (Trade Fair, Exhibitions, Conferences)

List of figures: nan
List of tables: nan
Companies Mentioned: nan